National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

benzydamine hydrochloride
An indazole non-steroidal anti-inflammatory drug (NSAID) with analgesic, antipyretic, and anti-edema properties. Unlike other NSAIDs, benzydamine hydrochloride does not inhibit cyclooxygenases (COX) but stabilizes membranes, resulting in local anesthesia; inhibits the production of pro-inflammatory cytokines; inhibits the generation of reactive oxygen species by neutrophils; inhibits leukocyte aggregation and adhesion; and exhibits antimicrobial properties. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:benzydamine HCl
US brand name:Difflam
Foreign brand name:Tantum



Previous:Benefin, Benemid, Beneo Synergy 1, Benoquin, benzoylphenylurea
Next:berubicin hydrochloride, beta carotene, beta-glucan, beta-lapachone, beta-thioguanine deoxyriboside

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov